Vismodegib and risk of cholestatic injury: should we screen candidate patients?
KeywordsMetformin Losartan Cholestasis Basal Cell Carcinoma Cholelithiasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Compliance with ethical standards
Conflict of interest
- 3.LoRusso PM, Piha-Paul SA, Mita M, et al. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential. Cancer Chemother Pharmacol. 2013;71:193–202.CrossRefPubMedGoogle Scholar
© Springer International Publishing Switzerland 2016